As botanical supplement portfolios become more diversified, brands are increasingly developing combination formulas rather than relying exclusively on single-ingredient products.
A botanical combination may bring together several standardized extracts, whole-herb powders, concentrated botanical ingredients, or complementary polyphenol systems within one finished product.
For OEM and private label manufacturing, however, combining several botanical ingredients is not simply a matter of adding individual raw materials to one formula.
Different botanical extracts can vary substantially in plant part, extraction solvent, extract ratio, carrier content, marker specifications, analytical methodology, bulk density, moisture profile, sensory characteristics, and regulatory status. These differences can influence both formulation performance and finished-product specifications.
Once multiple botanicals are blended, the formulation should therefore be evaluated as a complete manufacturing system.
For brands planning a botanical combination formula, the key question is not simply which ingredients should be combined, but:
How should each ingredient be specified, balanced, tested, manufactured, packaged, and documented for the intended market?
For brands looking for a botanical blend manufacturer or custom botanical formula manufacturer, early evaluation of ingredient compatibility, standardization strategy, and manufacturing feasibility is essential.
A single botanical extract allows the development team to focus on one raw material specification and one primary analytical profile.
A combination formula introduces additional variables.
Common development considerations include:
Ingredient variability can also affect formulation performance, stability, compatibility, and processing behavior.
For this reason, the procurement process should evaluate each botanical individually before evaluating the finished combination as a whole.
Not every botanical combination needs to use the same type of raw material.
A finished formula may include:
Standardized extracts are commonly selected when brands require defined specifications for one or more marker compounds.
Technical documentation may include:
A declared marker percentage should not be treated as a complete description of ingredient quality. Extract ratio, plant material, carrier content, analytical methodology, and identity documentation should also be reviewed.
Whole-herb powders may be selected when a product concept prioritizes minimally processed botanical materials.
Brands may evaluate:
Whole botanical powders may require larger serving sizes than concentrated extracts and may behave differently during blending and encapsulation.
Higher-strength extracts may be selected when the formulation requires a defined marker concentration within a relatively small serving size.
Technical review should include:
Higher marker concentration does not automatically mean that an ingredient is the better commercial choice.
The appropriate specification depends on the complete formula, dosage form, target dosage, cost structure, and target market.
One of the most important technical differences between a single botanical product and a combination formula is the number of analytical specifications that must be controlled.
For example, one formula may contain:
Each ingredient may require a different specification and analytical methodology.
These specifications should not automatically be reduced to one overall “botanical extract” specification.
Before placing an OEM order, brands should establish whether each botanical requires:
Fit-for-purpose analytical methods are important because identity and composition should be demonstrated using scientifically appropriate methods rather than relying on nonspecific characteristics alone.
Botanical procurement frequently involves specifications such as:
These terms describe different characteristics and should not be treated as interchangeable.
An extract ratio describes the relationship between the starting botanical material and the resulting extract.
A standardized marker specifies a defined level of a measured compound or group of compounds.
A native extract generally refers to the extract material before or without the addition of a carrier or other diluent, depending on the supplier’s specification.
Some extracts may contain carriers or excipients to improve handling, flowability, stability, or processing.
For procurement purposes, brands should compare the complete specification rather than selecting an ingredient solely because its marker percentage appears higher.
Once multiple botanical ingredients are blended, the finished formulation behaves as a new physical system rather than a simple combination of individual ingredients.
Different extracts may have substantially different:
Carrier content can become an important procurement consideration when multiple standardized botanical extracts are combined. Individual extracts may contain carriers, diluents, flow aids, anticaking agents, or other declared excipients depending on the extraction, drying, and standardization process.
For procurement review:
The presence and purpose of these materials should be reviewed because they may influence botanical content calculation, powder characteristics, clean-label positioning, and finished-product specifications.
When several carrier-containing extracts are used in the same formula, their combined contribution may influence the finished formula’s botanical content, excipient profile, serving size, cost structure, powder characteristics, and clean-label positioning.
Brands should therefore review the carrier content of each extract and calculate its contribution to the finished formula before finalizing ingredient specifications. Where clean-label positioning is important, manufacturers may also evaluate alternative specifications, including higher-native-extract or lower-carrier ingredient options, where technically and commercially feasible.
These differences, together with variations in bulk density, particle size, moisture content, and flow characteristics, can influence the manufacturing process.
For example, a fine, hygroscopic extract may behave very differently from a coarse botanical powder or a carrier-containing extract.
The formulation therefore needs to be evaluated for compatibility before commercial-scale production.
Powder behavior becomes particularly important when multiple botanical ingredients are combined.
Technical evaluation should focus on:
Ingredients with substantially different particle sizes, densities, or flow characteristics may separate during processing stages such as mixing, transfer, filling, or transportation.
Segregation can affect blend uniformity and the consistency of individual portions.
For combination formulas, the manufacturing process should therefore be evaluated together with the physical properties of the raw materials.
Botanical combination formulas can also create sensory challenges that are not obvious when each ingredient is evaluated individually.
Potential variables include:
These factors can become especially important in:
A botanical extract that is practical for a capsule may require additional formulation work when used in a flavored powder or gummy.
Adding more ingredients does not automatically create a stronger commercial proposition.
For OEM and private label development, the objective is not to maximize the number of ingredients in a formula. The goal is to create a formula that is commercially viable, technically controllable, and suitable for the intended market.
A commercially successful botanical formula should be:
A formula containing fewer but well-defined botanical ingredients may provide stronger long-term commercial value than a complex formula with limited specification control.
However, increasing the number of botanical extracts can introduce additional formulation challenges, including:
For this reason, a focused formula containing two to four well-defined botanical ingredients may sometimes be easier to manufacture, validate, and position than a much longer ingredient list.
The appropriate number of ingredients depends on the formulation objective, dosage form, target consumer, target market, and commercial strategy.
Botanical combination formulas are usually developed around a specific product concept, target consumer, dosage form, and market strategy.
Rather than selecting multiple ingredients first, successful product development usually starts with defining the intended product architecture.
Common development pathways include:
Healthy aging concepts often require careful selection of standardized botanical extracts, polyphenol-focused ingredient systems, and practical dosage strategies.
Development considerations may include:
Active lifestyle products may require a balance between formulation concept, serving size, and convenient delivery formats.
Technical considerations may include:
Women’s wellness concepts often require additional review of ingredient status, cumulative intake, consumer advisory considerations, and target-market requirements.
Development considerations may include:
These pathways represent product development approaches rather than specific health claims. The final formula should always be evaluated based on ingredient specifications, manufacturing feasibility, intended market, and applicable regulatory requirements.
Development Path
Advantages
Key Considerations
Single Botanical
Simple specification and positioning
Less formulation differentiation
2–3 Botanical Formula
Moderate complexity and differentiation
Requires compatibility review
Multi-Botanical Formula
Broader formulation concept
Higher analytical and manufacturing complexity
Pre-Blended Botanical System
Simplified handling
Less control over individual components
Custom OEM Formula
Greater control over formula architecture
Requires more development and documentation
For emerging brands, a focused two- or three-ingredient formula may provide a practical starting point.
For established brands, a more complex combination may be appropriate when the ingredient specifications, dosage strategy, target market, and manufacturing process have been clearly defined.
Depending on product positioning, combination formulations may incorporate:
The commercial positioning should be established before finalizing the ingredient combination.
The formulation should then be evaluated against:
This approach helps prevent a formula from becoming unnecessarily complex simply because additional ingredients appear commercially attractive.
When multiple botanical extracts are combined, formula review should consider not only the individual specification of each ingredient but also the cumulative intake of overlapping or related bioactive constituents across the complete formulation.
A botanical combination formula should therefore be evaluated for:
For example, two botanical extracts may each have an acceptable specification individually, but their combined contribution of similar or related active constituents should still be reviewed at the finished-formula level.
This evaluation helps brands avoid assessing ingredients separately while overlooking the overall composition of the final product.
Combination botanical formulas require additional review because the finished product may contain multiple ingredients with different safety, interaction, and labeling considerations.
Depending on the target market and product classification, brands may need to review:
Combination formulations may create additional claim, safety, interaction, analytical testing, and consumer advisory requirements beyond their manufacturing complexity.
The presence of several botanicals should therefore trigger a complete formula-level review rather than separate ingredient-level assessments only.
When multiple concentrated botanical extracts are combined, brands should evaluate the cumulative daily intake of relevant bioactive constituents, potential botanical-drug interactions, intended-user restrictions, and market-specific safety or labeling requirements. These considerations should be reviewed at the finished-formula level rather than assessed only for each individual ingredient.
Capsules are often suitable for concentrated botanical extracts when the total powder load remains practical.
Key considerations include:
Tablets may be considered when brands require:
However, botanical extracts can vary significantly in compressibility and flowability.
Pilot-scale evaluation may therefore be required before finalizing the tablet formula.
Powder formats can accommodate larger serving sizes than capsules and may be suitable for flavored botanical drink mixes.
Important variables include:
Gummies and jelly sticks introduce additional formulation variables because botanical extracts must remain compatible with the finished matrix.
Technical considerations may include:
A botanical extract suitable for capsules may require a different formulation strategy for gummies or jelly sticks.
Liquid botanical formulas require additional review of:
A highly concentrated botanical extract may therefore require a different delivery strategy from a water-soluble botanical powder.
Packaging should be selected after considering the combined physical and stability characteristics of the formula.
Common packaging options include:
Key considerations may include:
For larger serving-size powders, pouches may provide a practical packaging configuration.
For individual daily servings, stick packs may provide portion control and convenient distribution.
For capsule and tablet products, HDPE bottles, glass bottles, or blister packaging may be considered depending on the target market and product positioning.
Packaging should be treated as part of the product specification rather than as a final cosmetic decision. U.S. dietary supplement CGMP requirements, for example, include specifications for packaging that contacts the supplement and for finished packaged products.
Regulatory requirements differ across international markets.
Before commercialization, brands should review ingredient suitability, formulation specifications, labeling requirements, supporting documentation, and applicable regulatory frameworks for each intended market.
Common commercial markets include:
For U.S. projects, brands should review the regulatory status of each botanical ingredient, applicable dietary supplement requirements, labeling requirements, ingredient documentation, and intended product positioning.
Component and finished-product specifications should be established as part of the manufacturing quality system.
For Australian projects, botanical combination products may fall within different regulatory pathways depending on ingredient status, dosage form, claims, and product presentation.
Sponsors should review current permissible ingredient requirements, applicable restrictions, permitted indications, evidence expectations, label statements, and the appropriate ARTG pathway before finalizing the formula or marketing position.
For New Zealand projects, brands should separately review dietary supplement classification, ingredient requirements, labeling obligations, and applicable restrictions.
Australia and New Zealand should not automatically be treated as having identical regulatory requirements.
For European Union projects, brands should review each botanical ingredient individually as well as the finished combination formula.
Ingredient source, plant part, extraction process, composition, history of use, and intended product presentation may affect the applicable regulatory assessment.
The regulatory status of one botanical ingredient should not automatically be assumed to determine the status of the complete combination formula.
For UK projects, brands should separately review ingredient status, product classification, labeling requirements, permitted claims, and supporting documentation under the applicable UK framework.
Before finalizing a botanical combination formula, brands should complete a manufacturing feasibility review to confirm that the proposed formula can be produced consistently at commercial scale.
A typical OEM feasibility review covers:
A feasibility review helps identify formulation, manufacturing, quality, and documentation risks before commercial production.
Before requesting a Botanical Combination Formula OEM quotation, brands should prepare:
Providing these details early can improve the accuracy of formulation feasibility, MOQ, cost, lead-time, and documentation assessment.
Not necessarily. The appropriate approach depends on the formulation objective, dosage form, target consumer, target market, and commercial positioning.
No.
Not automatically.
There is no universal number.
There is no single best format.
At minimum, brands should provide the proposed botanical ingredients, target specifications, dosage form, target market, packaging preference, and expected order volume.
Whether you choose standard China OEM or hybrid manufacturing, we’re here to support your nutraceutical brand development.
To review formulation development, pilot trials, and technology transfer support before commercialization, explore our ULTRA Global Supplement Development & Technology Transfer Center.
To compare broader botanical product development pathways, explore our Botanical Supplements Manufacturing Guide.
To prepare manufacturing documentation before commercialization, review our Documentation Readiness Guide.
To explore individual botanical OEM manufacturing pathways, review our Ashwagandha, Berberine, Turmeric, Boswellia, Ginkgo Biloba and Olive Leaf Extract supplement manufacturing guides.
Share this page to